News

AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, announced findings from two new studies that further support the use of its portable ECG devices to provide groundbreaking health monitoring...

Portola Pharmaceuticals, Inc.® announced new interim results from ANNEXA-4, the Company’s ongoing Phase 3b/4 trial of its investigational universal Factor Xa inhibitor antidote AndexXa® (andexanet alfa) among patients experiencing...

Bristol-Myers Squibb Company and Pfizer Inc. will present findings from a real-world data (RWD) analysis titled, Comparison of Effectiveness, Safety, and the Net Clinical Outcome between Different Direct Oral Anticoagulants in 162,707...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced late-breaking results of a new home-based clinical trial showing that a wearable continuous electrocardiogram (ECG) monitoring patch can identify people with...

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, announced enrollment of the first patients in the global SOLVE-CRT (Stimulation of the Left Ventricular Endocardium for Cardiac...

EPD's Cardiac Mapping and Navigation System has received CE mark approval. The system helps electrophysiologists navigate the heart by generating an accurate 3D map, while imaging and pinpointing the exact location and orientation of...

BIOTRONIK’s latest offering of pacemaker systems, now approved for 3 tesla (T) full-body MRI scans (FBS), launched in Japan. The Evity series of single- (SR-T) and dual-chamber (DR-T) pacemakers are outfitted with MRI AutoDetect, which...

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, announced clinical results from GENETIC-AF, a Phase 2B,...

CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), announced the initiation of a clinical evaluation of the new HeartLight X3...

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), announced that it has launched the AtriClip FLEX•V™ Left Atrial Appendage (LAA) Exclusion System in the United...